Related Experiment Video

Updated: Aug 6, 2026

Forskolin-induced Swelling in Intestinal Organoids: An In Vitro Assay for Assessing Drug Response in Cystic Fibrosis Patients
07:04

Forskolin-induced Swelling in Intestinal Organoids: An In Vitro Assay for Assessing Drug Response in Cystic Fibrosis Patients

Published on: February 11, 2017

Update on clinical trials of cystic fibrosis

N R Henig1, M L Aitken

  • 1Department of Medicine, University of Washington Medical Center, Seattle 98112, USA.

Current Opinion in Pulmonary Medicine
|December 10, 1997
PubMed

Insights

This review summarizes key cystic fibrosis (CF) clinical research, focusing on gene therapy and cellular biology. It also covers mucociliary transport, inhaled tobramycin, and nonpulmonary treatments for CF liver disease and infertility.

Area of Science:

  • Medical Research
  • Genetics
  • Pulmonology

Background:

  • Cystic Fibrosis (CF) is a genetic disorder affecting multiple organs.
  • Understanding CF transmembrane regulator (CFTR) protein function is crucial.
  • Current research addresses various aspects of CF management.

Purpose of the Study:

  • To review significant advancements in clinical research for cystic fibrosis.
  • To highlight ongoing gene therapy and cellular biology studies.
  • To discuss treatments with immediate clinical impact and nonpulmonary interventions.

Main Methods:

  • Literature review of ongoing and recently published clinical trials.
  • Focus on studies investigating CFTR protein correction or bypass mechanisms.
  • Inclusion of trials evaluating symptomatic treatments and non-organ specific therapies.

Main Results:

  • Gene therapy research is progressing, though many trials are ongoing.
  • Studies on CF cellular biology aim to understand and correct CFTR defects.
  • Trials for mucociliary transport and inhaled tobramycin show clinical promise.
  • Nonpulmonary treatments like ursodeoxycholic acid and intracytoplasmic sperm injection are important for CF patients.

Conclusions:

  • Clinical research in CF is multifaceted, encompassing genetic, cellular, and symptomatic approaches.
  • While gene therapy is a long-term goal, immediate benefits are seen from improved airway clearance and targeted antibiotics.
  • Comprehensive management of CF includes addressing nonpulmonary complications to improve overall patient health and fertility.

More Related Videos

Standardized Measurement of Nasal Membrane Transepithelial Potential Difference (NPD)09:47

Standardized Measurement of Nasal Membrane Transepithelial Potential Difference (NPD)

Published on: September 13, 2018

Generation of Human Nasal Epithelial Cell Spheroids for Individualized Cystic Fibrosis Transmembrane Conductance Regulator Study08:00

Generation of Human Nasal Epithelial Cell Spheroids for Individualized Cystic Fibrosis Transmembrane Conductance Regulator Study

Published on: April 11, 2018

Related Concept Videos

Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...